News | August 12, 2021
KK Pant is the new NPPA chairman
It plays a pivotal role in monitoring pharmaceutical pricing
It plays a pivotal role in monitoring pharmaceutical pricing
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
The drug is indicated for mild and transient episodes of heart block
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Turnover of API division of ISLL stood at Rs 856.58 crore
Subscribe To Our Newsletter & Stay Updated
